BH3-Only proteins-essential initiators of apoptotic cell death - PubMed (original) (raw)

Review

. 2000 Dec 8;103(6):839-42.

doi: 10.1016/s0092-8674(00)00187-2.

Affiliations

• PMID: 11136969
• DOI: 10.1016/s0092-8674(00)00187-2

Free article

Review

BH3-Only proteins-essential initiators of apoptotic cell death

D C Huang et al. Cell. 2000.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death.
  Bouillet P, Strasser A. Bouillet P, et al. J Cell Sci. 2002 Apr 15;115(Pt 8):1567-74. doi: 10.1242/jcs.115.8.1567. J Cell Sci. 2002. PMID: 11950875 Review.
• Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.
  Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N. Oda E, et al. Science. 2000 May 12;288(5468):1053-8. doi: 10.1126/science.288.5468.1053. Science. 2000. PMID: 10807576
• BCL-2 family members and the mitochondria in apoptosis.
  Gross A, McDonnell JM, Korsmeyer SJ. Gross A, et al. Genes Dev. 1999 Aug 1;13(15):1899-911. doi: 10.1101/gad.13.15.1899. Genes Dev. 1999. PMID: 10444588 Review. No abstract available.
• BID: a novel BH3 domain-only death agonist.
  Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ. Wang K, et al. Genes Dev. 1996 Nov 15;10(22):2859-69. doi: 10.1101/gad.10.22.2859. Genes Dev. 1996. PMID: 8918887
• Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1.
  Yasuda M, Chinnadurai G. Yasuda M, et al. Oncogene. 2000 May 4;19(19):2363-7. doi: 10.1038/sj.onc.1203565. Oncogene. 2000. PMID: 10822388

Cited by

• Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope.
  Zhang X, Tang B, Luo J, Yang Y, Weng Q, Fang S, Zhao Z, Tu J, Chen M, Ji J. Zhang X, et al. Mol Cancer. 2024 Nov 15;23(1):255. doi: 10.1186/s12943-024-02130-8. Mol Cancer. 2024. PMID: 39543600 Free PMC article. Review.
• Fine particulate matter‑induced cardiac developmental toxicity (Review).
  Meng X, Du W, Sun Z. Meng X, et al. Exp Ther Med. 2024 Oct 29;29(1):6. doi: 10.3892/etm.2024.12756. eCollection 2025 Jan. Exp Ther Med. 2024. PMID: 39534282 Free PMC article. Review.
• The prognostic significance of genetics in acute myeloid leukemia under venetoclax-based treatment.
  Zheng S, Tong Y, Yang L, Chen J, Tan Y. Zheng S, et al. Ann Hematol. 2024 Oct 29. doi: 10.1007/s00277-024-06050-x. Online ahead of print. Ann Hematol. 2024. PMID: 39467855 Review.
• Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation.
  Enzenmüller S, Niedermayer A, Seyfried F, Muench V, Tews D, Rupp U, Tausch E, Groß A, Fischer-Posovszky P, Walther P, Stilgenbauer S, Kestler HA, Debatin KM, Meyer LH. Enzenmüller S, et al. Cell Death Dis. 2024 Jul 3;15(7):475. doi: 10.1038/s41419-024-06864-7. Cell Death Dis. 2024. PMID: 38961053 Free PMC article.
• Tumor biomarkers for diagnosis, prognosis and targeted therapy.
  Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, Tian X, Guan X, Cen X, Zhao Y. Zhou Y, et al. Signal Transduct Target Ther. 2024 May 20;9(1):132. doi: 10.1038/s41392-024-01823-2. Signal Transduct Target Ther. 2024. PMID: 38763973 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database